Intanza®: a new intradermal vaccine for seasonal influenza
Authors:
- Robert L AtmarRARobert L Atmar
- Shital M PatelSPShital M Patel
- Wendy A KeitelWKWendy A Keitel
- 1 December 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 9 (12) , 1399-1409
Abstract
Seasonal influenza causes annual epidemics in temperate climates and is associated with economic costs, morbidity and mortality. Vaccination is the primary method of prevention. Intanza(®) (Sanofi Pasteur, Lyon, France) is a newly licensed, trivalent, inactivated influenza vaccine that is delivered intradermally with a proprietary micoinjection system. Two dosage formulations have been approved for use in Europe and Australia. The dosage level of 9 µg of hemagglutinin per strain is approved for persons 18-59 years of age, and its immunogenicity is noninferior to the standard dosage (15 µg per strain) administered intramuscularly. In addition, the dosage level of 15 µg of hemagglutinin per strain administered intradermally is approved for persons 60 years of age and older and has superior immunogenicity compared with that induced by the same dosage administered intramuscularly. Intanza has more frequent injection-site reactions than intramuscularly delivered vaccine, but it is safe and well tolerated. Intanza provides a new option for the prevention of influenza.Keywords
This publication has 50 references indexed in Scilit:
- Deaths From Seasonal Influenza Among Pregnant Women in the United States, 1998–2005Obstetrics & Gynecology, 2010
- Influenza Excess Mortality from 1950–2000 in Tropical SingaporePLOS ONE, 2009
- Incidence, Seasonality and Mortality Associated with Influenza Pneumonia in Thailand: 2005–2008PLOS ONE, 2009
- The annual impact of seasonal influenza in the US: Measuring disease burden and costsVaccine, 2007
- Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjectsEuropean Heart Journal, 2007
- Influenza-Associated Deaths among Children in the United States, 2003–2004New England Journal of Medicine, 2005
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the United StatesJAMA, 2003
- Influenza: Its Control in Persons and PopulationsThe Journal of Infectious Diseases, 1986
- Interpandemic Influenza in the Houston Area, 1974–76New England Journal of Medicine, 1978